arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

QUEST DIAGNOSTICS INC

DGX
$254.68 ▼ -0.84 (-0.33%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
76 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Bullish
auto_awesome

Analytical Summary

QUEST DIAGNOSTICS INC shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $28.0B
Dividend Yield 0.34%
Revenue Growth 10.0% ↘
Op. Margin 15.5% ↗
ROIC 2.9% ↗
FCF / Share $4.05 ↘
Trailing P/E 90.3x
Price / Book 3.7x
FCF Yield 1.6%
Debt / Equity 0.73
info Valuation on last close. End-of-day price, Nov 5, 2026.

76-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.10B
↑ +10.0% —
Net Income Profit after all expenses
$312.00M
↑ +27.3% —
Operating Margin Operating profit as % of sales
15.5%
↑ +2.5% 65th
FCF / Share Free cash flow per share
$4.05
↓ -2.2% —
Long-Term Debt Long-term obligations
$5.55B
↓ -1.6% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
65
Returns ↓
78
Financial Health →
55
Cash Quality ↑
78

Dividend History

Dividend / share · sourced from SEC filings
$1.80 Latest / share
+9.1% YoY
+10.9% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 20 years · 76 quarters